Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China flag China · Delayed Price · Currency is CNY
89.75
-1.61 (-1.76%)
Sep 4, 2026, 3:04 PM CST

SHE:300436 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
164.08213.93143.95202.83238.98393.57
Cash & Short-Term Investments
164.08213.93143.95202.83238.98393.57
Cash Growth
99.02%48.61%-29.03%-15.13%-39.28%189.41%
Accounts Receivable
80.0388.9570.4369.7647.9754.26
Other Receivables
7.0728.428.83258.214.94
Receivables
87.1117.3599.2694.7656.1859.2
Inventory
128.92124.85114.48111.4868.6681.8
Other Current Assets
83.4955.2949.6140.2230.4815.32
Total Current Assets
463.59511.42407.3449.29394.3549.89
Property, Plant & Equipment
510531.51588.4639.49584.83509.63
Long-Term Investments
70.7473.0180.18108.81170.7499.98
Goodwill
58.9758.9758.9758.9758.9758.97
Other Intangible Assets
150.27162.77251.66292.08100.83118.93
Long-Term Deferred Tax Assets
2.352.131.471.1571.0743.07
Long-Term Deferred Charges
79.2257.8742.7847.7555.2232.56
Other Long-Term Assets
3.692.88.0616.9458.8733.74
Total Assets
1,3391,4001,4391,6141,4951,447

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Accounts Payable
178.5490.5353.3849.2922.2785.53
Accrued Expenses
8.02117.37174.67175.3489.0538.62
Short-Term Debt
178.04144.15182.18219.18209.2777.76
Current Portion of Long-Term Debt
116.5267.54117.9272.1217.9462.47
Current Portion of Leases
-0.160.10.180.190.11
Current Income Taxes Payable
5.992.272.911.673.83.77
Current Unearned Revenue
10.373.883.5711.918.226.63
Other Current Liabilities
42.7746.1340.0568.0757.827.42
Total Current Liabilities
540.25472.02574.78597.76408.55302.31
Long-Term Debt
181.06244.08142.36167.6984.0447
Long-Term Leases
0.890.04-0.090.1-
Long-Term Unearned Revenue
56.8860.3565.9939.9942.3345.56
Long-Term Deferred Tax Liabilities
2.082.12.672.382.422.05
Other Long-Term Liabilities
285.12275.59256.24237.311.79-
Total Liabilities
1,0661,0541,0421,045539.22396.92

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Common Stock
159.27159.27159.27159.27159.27158.78
Additional Paid-In Capital
743.12743.12607.93607.93671.32659.29
Retained Earnings
-693-624.86-407.01-250.7197.88225.28
Total Common Equity
209.39277.53360.18516.48928.461,043
Minority Interest
63.1568.7736.652.7627.166.49
Shareholders' Equity
272.54346.3396.78569.24955.621,050
Total Liabilities & Equity
1,3391,4001,4391,6141,4951,447

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Total Debt
476.52455.97442.56459.27311.55187.33
Net Cash (Debt)
-312.44-242.03-298.6-256.44-72.57206.24
Net Cash Growth
------
Net Cash Per Share
-1.96-1.52-1.87-1.61-0.461.38
Filing Date Shares Outstanding
159.31159.27159.27159.27159.27158.78
Total Common Shares Outstanding
159.31159.27159.27159.27159.27158.78
Working Capital
-76.6739.4-167.48-148.48-14.25247.58
Book Value Per Share
1.311.742.263.245.836.57
Tangible Book Value
0.1555.7949.56165.44768.66865.45
Tangible Book Value Per Share
0.000.350.311.044.835.45
Buildings
-557.06561.67565.02536.94397.03
Machinery
-271.69271.55268.43179.92116.23
Construction In Progress
-21.729.7629.8650.6147.22